11. A Critical Role for Immune System Response in Mediating Anti‐influenza Drug Synergies Assessed by Mechanistic Modeling. (10th September 2014) Authors: Li, Z; Zhou, H; Lu, Y; Colatsky, T Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 9(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. A Flexible Approach for Context‐Dependent Assessment of Quantitative Systems Pharmacology Models. (14th May 2019) Authors: Ramanujan, Saroja; Chan, Jason R.; Friedrich, Christina M.; Thalhauser, Craig J. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 8:Number 6(2019) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. A framework to guide dose & regimen strategy for clinical drug development. (25th September 2021) Authors: Sander, Oliver; Magnusson, Baldur; Ludwig, Inga; Jullion, Astrid; Meille, Christophe; Lorand, Daniel; Bornkamp, Björn; Hinder, Markus; Kovacs, Steven J.; Looby, Michael Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 11(2021) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. A General Framework for Assessing In vitro/In vivo Correlation as a Tool for Maximizing the Benefit‐Risk Ratio of a Treatment Using a Convolution‐Based Modeling Approach. (5th February 2019) Authors: Gomeni, Roberto; Fang, Lanyan (Lucy); Bressolle‐Gomeni, Françoise; Spencer, Thomas J.; Faraone, Stephen V.; Babiskin, Andrew Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 8:Number 2(2019) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. A General Network Pharmacodynamic Model–Based Design Pipeline for Customized Cancer Therapy Applied to the VEGFR Pathway. (15th January 2014) Authors: Zhang, X‐Y; Birtwistle, MR; Gallo, JM Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 1(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. A generic framework for the physiologically‐based pharmacokinetic platform qualification of PK‐Sim and its application to predicting cytochrome P450 3A4–mediated drug–drug interactions. (24th May 2021) Authors: Frechen, Sebastian; Solodenko, Juri; Wendl, Thomas; Dallmann, André; Ince, Ibrahim; Lehr, Thorsten; Lippert, Jörg; Burghaus, Rolf Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 6(2021) Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. A Generic Integrated Physiologically based Whole‐body Model of the Glucose‐Insulin‐Glucagon Regulatory System. (14th August 2013) Authors: Schaller, S; Willmann, S; Lippert, J; Schaupp, L; Pieber, TR; Schuppert, A; Eissing, T Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 2:Number 8(2013:Aug.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development. (5th February 2019) Authors: Madabushi, Rajanikanth; Wang, Yaning; Zineh, Issam Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 8:Number 1(2019) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors. (26th July 2021) Authors: Hughes, Jasmine H.; Keizer, Ron J. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 10(2021) Page Start: 1150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration‐Resistant Prostate Cancer1. (24th April 2015) Authors: Wilbaux, M; Tod, M; De Bono, J; Lorente, D; Mateo, J; Freyer, G; You, B; Hénin, E Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 5(2015:May) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗